+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

System Suitability Testing (SST) for USP and FDA Compliance - Webinar (Recorded)

  • Webinar

  • 90 Minutes
  • June 2018
  • Compliance Online
  • ID: 4542960
Why Should You Attend:

System suitability testing (SST) is required by USP and FDA to check and ensure ongoing performance of an analytical systems and methods. Both USP and EP have chapters with recommendations for system suitability tests that are enforced by FDA and EMA. Related chapters have been updated by USP and EP and they also answer the question as to how much a method can be changed without the need for revalidation. Also, the USP chapter < 1058> makes a statement that SST can substitute an instrument's performance qualification, but not further guidelines are given. So there are many questions. This webinar will give participants a good understanding of FDA and USP requirements for system suitability testing.

Areas Covered in the Webinar:

FDA and international requirements for system suitability testing
Examples of FDA warning letters and how to avoid them
The role of SST for analytical quality assurance
SST in comparison with equipment qualification and quality control sample analysis
Most critical parameters for SST in EP and USP
Contents of the updated USP chapter < 621>
Recommendations for implementing the updated < 621>
Developing an SOP for system testing
Criteria for SST timing within a sequence of sample runs
Using software for automated system suitability control
The role of SST for method changes according to the updated chapter < 621>
Case studies with practical advice for test parameters and limits
Documenting SST test runs


Dr. Ludwig Huber, Ph.D., is the director of Labcompliance and editor of www.labcompliance.com, the global online resource for validation and compliance. Dr. Huber is the author of the books "Validation and Qualification in Analytical Laboratories" and "Validation of Computerized Analytical and Networked Systems". He has given multiple presentations mainly on GLP/GMP, 21 CFR Part 11 and Validation around the world. This included seminars, workshops and presentations for the US FDA, China SFDA, Korea MFDS, Singapore HSA, ISPE, Japan PDA, PIC/S and several other national health care agencies.